Atrial Fibrillation Market 2018 by Global Technologies Analysis of Top Companies (Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic, Philips Healthcare) and Forecast Till 2023

Atrial Fibrillation: Technologies and Global Markets 2018-2023:
The global market for atrial fibrillation (AFib) was valued at $REDACTED billion in 2017 and is expected toincrease at a CAGR of REDACTED% to reach a value of $REDACTED billion by 2023. Growth of the market is driven bythe increase in the prevalence of AFib and the launch of premium priced ablation catheters, diagnosticmapping catheters and LAA closure devices in developed countries of the world, namely the U.S.,Western Europe and Japan. One of the biggest challenges to this market is the lack of adequateavailability of skilled electrophysiologists and interventional cardiologists.

Download a PDF Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/2359071

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

Devices included as a part of market estimates are:
- Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables.
- Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.

Devices excluded from market estimates are:
- Pharmacological drugs employed in standalone and combination of ablation procedures.
- Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors).
- ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices.
- Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices.
- Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.

The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

Enquiry before buying report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2359071

The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

Report Includes:

- 25 data tables and 13 additional tables
- An overview of the global market for atrial fibrillation and technologies
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
- Discussion of the types of atrial fibrillation treatment
- A look into various government regulations
- Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
- Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare

Report Scope:

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

Devices included as a part of market estimates are:
- Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables.
- Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.

Devices excluded from market estimates are:
- Pharmacological drugs employed in standalone and combination of ablation procedures.
- Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors).
- ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices.
- Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices.
- Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.

The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

Access the complete report with TOC & List of Tables @ http://www.orbisresearch.com/reports/index/atrial-fibrillation-technologies-and-global-markets

Report Includes:
- 25 data tables and 13 additional tables
- An overview of the global market for atrial fibrillation and technologies
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
- Discussion of the types of atrial fibrillation treatment
- A look into various government regulations
- Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
- Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare

Companies Mentioned:
• ABBOTT LABORATORIES
• ABLACOR MEDICAL CORP.
• ACUTUS MEDICAL INC
• AEGIS MEDICAL INNOVATIONS
• AFREEZE GMBH
• ATRICURE INC
• AURIS HEALTH (HANSEN MEDICAL)
• BIOTRONIK
• BOSTON SCIENTIFIC
• CARDIOFOCUS
• CATHRX
• GE HEALTHCARE
• JOHNSON & JOHNSON
• KARDIUM
• LIFETECH SCIENTIFIC CORP.
• LUXCATH
• MEDTRONIC
• MICROPORT SCIENTIFIC CORP.
• PHILIPS HEALTHCARE
• SENTREHEART
• STEREOTAXIS

Download Free PDF Sample: http://www.orbisresearch.com/contacts/request-sample/2359071

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Background
Heart Structure and Function
Cardiac Arrhythmia
Treadmill Run Test Stress Test
Holter Monitoring
Echocardiography
Electrophysiologic Testing
Atrial Fibrillation (AFib)
Symptoms
Global Epidemiology
Economic Burden of Atrial Fibrillation
Risk Factors
Complications of Atrial Fibrillation
Patterns of Atrial Fibrillation
Current Standard of Care for Atrial Fibrillation
Diagnosis
Treatment of AFib
Chapter 4 Market Overview
Market Dynamics
Market Drivers
Market Restraints
Emerging Trends
Regulatory Landscape
Regulation in Europe
Regulation in the U.S.
Regulation in Japan
Regulation in China
Regulation in India
Chapter 5 Market Breakdown by Device Type
Introduction and Global Markets
Catheter Ablation Devices
Overview
Market Size and Forecast
Catheter Ablation Devices by Type
Left Atrial Appendage (LAA) Closure Devices
Overview
Cost Benefits of Left Atrial Appendage Closure Devices vs. Pharmacological Therapy
Market Size and Forecast
Types of Left Atrial Appendage Implantation
Chapter 6 Market Breakdown by Region

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.